RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Transport of dopamine (DA) by the dopamine transporter from the synaptic cleft into the presynaptic terminals plays a key role in terminating dopaminergic neurotransmission. The binding of psychostimulants to their recognition sites on the DA transporter leads to an inhibition of DA transport and a subsequent rising of the dopamine contents in the synaptic cleft is
ascribed to a mode of psychostimulation. Discovery of dopamine transporter inhibitors would be useful with regard to substituting for cocaine and minimizing its abuse. Recently, a number of fluoxetine analogues were synthesized, especially focusing on the substitution of N-methyl amine group through modifying the structure of the fluoxetine, N-methyl-3-[p-trifluoromethylphenoxy]-3-phenylpropylamine, widely used as an antidepressant. Among them, the pharmacological properties of FD-2, (R)-N-ethanol-3-(4-trifluorophenoxy)-3-phenyl propaneamine and FD-4, N-(R)-3-trifluorophenoxy-3-phenylpropane-imidazole with a higher affinity for the DA
transporter were characterized in terms of dopamine transporter inhibition expecting for useful cocaine substitutes. Effects of the compounds on [H3]dopamine uptake, [I125]RTI-55 binding, and DA transporter-associated currents were examined with the ligand binding assays and voltage clamping technique in human embryonic kidney (HEK)-293 cells where the recombinant
human DA transporter (hDAT) was stably expressed. Our results showed that (i) fluoxetine was potent in inhibiting both the uptake of [H3]DA (IC50 = 0.21 ± 0.032 mM, n = 3) and the [I125]RTI-55 binding (IC50 = 0.23 ± 0.012 mM, n = 10); (ii) N-methyl amine substituted fluoxetine analogues, FD-2 and FD-4 were equally or more potent than fluoxetine itself in terms of inhibition of [H3]DA uptake (IC50 FD-2: 0.077 ± 0.0032 mM (n = 3); FD-4: 0.26 ± 0.13 mM (n = 3), inhibition of [I125]RTI-55 binding, and reduction in DA transporter-associated currents, suggesting that these analogues could be a new class of dopamine transporter inhibitors.

참고문헌 (Reference)

1 Iversen L. L., "Uptake processes for biogenic amines. in: Handbook of psychopharmacology,vol 3" Plenum Press 381-442, 1975

2 Harris, J. E., "Uptake of [3H]catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues" 12 : 669-679, 1973

3 Hill, A. V., "The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves" 138 : 194-1910, 1910

4 Andersen, P. H., "The dopamine uptake inhibitor GBR12909: Selectivity and molecular mechanism of action" 166 : 493-504, 1989

5 Kuhar M. J., "The dopamine hypothesis of the reinforcing properties of cocaine" 14 : 299-302, 1991

6 Kuhar, M. J., "Synaptosome from forebrains of rats with midbrain raphe lesion: selective reduction of serotonin uptake" 181 : 36-45, 1972

7 Heikkila, R. E., "Studies on the distinction between uptake inhibition and release of [3H] dopamine in rat brain tissue slices" 103 : 241-248, 1975

8 Galli, A., "Sodium-dependent norepinephrine-induced currents in norepinephrine transporter transfected HEK-293 cells blocked by cocaine and antidepressants" 198 : 2197-2212, 1995

9 Chae, Y.-M., "Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction" 13 : 430-439, 2006

10 Qian, Y., "Protein Kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression" 17 : 45-57, 1997